Recce Pharmaceuticals (ASX:RCE) Achieves Phase II Trial Milestone
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Recce Pharmaceuticals (ASX:RCE) successfully dosed all patients in its Phase II trial for R327 topical gel, showing promising preliminary results.
Centrex Limited (ASX:CXM) unveils an entitlement offer to raise A$10.4 million for operational and infrastructural advancements.
Wellnex Life (ASX:WNX) updates on Pain Away acquisition funding and future dual listing plans.
Ballymore Resources (ASX:BMR) is set to commence a 2,000m drilling program at the Dittmer Gold Project in February.
Ava Risk Group Limited (ASX: AVA) reports a strong Q2 FY2025 with significant revenue growth and positive EBITDA.
Power Minerals Limited reports significant progress in drilling at the Nióbio Project, Brazil, with results expected in Q1 2025.
Iron Road Ltd (ASX:IRD) reports milestone payments received and project advancements at Cape Hardy.
Wesfarmers announces the wind down of Catch to strengthen its retail divisions and enhance the omnichannel customer experience.
Tivan Limited produces high-purity vanadium pentoxide at the Speewah Project, advancing vanadium electrolyte testing and commercial viability.
BHP reports a significant operational performance increase with a 10% rise in copper production and strategic developments for future growth.